News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Coherent launched PhotonLink, an integrated optics platform for AI datacenters, and expects revenue ramp beginning Q4 2026.
  • Anaptys reported Q2 strength with Jemperli net sales up 34% to $644 million, boosting revenue and net income.
  • The FDA set a PDUFA action date of February 2027 for Jemperli in rectal cancer.
  • newcleo closed a $247 million SPAC business combination and will begin trading on Nasdaq as NWCL on September 22, 2026.
  • Abivax raised €767.1 million in a US offering, completed a royalty buy-back, and extended cash runway into Q4 2029.
  • Gauzy received a Nasdaq delisting notice for sub-$1 share price and missed filings and said it will appeal.

Latest Articles

US Authorities Confiscate Over 700 Drones Near World Cup Venues

US Authorities Confiscate Over 700 Drones Near World Cup Venues

Since the World Cup began on June 11, U.S. law enforcement and aviation agencies have seized more than 700 unmanned aircraft near tournament stadiums and fan zones across all 11 host cities. The FBI and FAA say strict temporary flight restrictions on match days and at fan gatherings have been enforced, with several arrests and the threat of heavy f…

Pentagon to Require Annual Testosterone Checks for Service Members Aged 30 and Up

Pentagon to Require Annual Testosterone Checks for Service Members Aged 30 and Up

Defense Secretary Pete Hegseth has ordered mandatory yearly testosterone testing for U.S. troops aged 30 and older, an initiative presented as a way to detect and treat age-related testosterone decline. Service members under 30 may request testing, and any recommended replacement therapy would be voluntary. The announcement has prompted criticism f…

AMD: Buy the CPU Upside Into Aug. 4 Earnings - Mid‑term Trade Idea

AMD: Buy the CPU Upside Into Aug. 4 Earnings - Mid‑term Trade Idea

Advanced Micro Devices (AMD) sits squarely in the crosshairs of the agentic AI-driven server refresh. The stock has pulled back from its June highs and offers a tradeable entry into what could be another leg higher if August earnings confirm accelerating server CPU demand. This is a mid-term swing trade designed to capture the post-earnings re-rati…

Fed Inspector General Flags Gaps in Protections for Sensitive Economic Information

Fed Inspector General Flags Gaps in Protections for Sensitive Economic Information

The Federal Reserve's internal watchdog found that the central bank's protections for proprietary economic information are insufficient, citing weaknesses in risk identification, insider controls, training and information sharing. The Office of Inspector General urged the Board to adopt nine recommendations to better define critical assets and eval…

Aptorum Group Provides Update on DiamiR Biosciences Merger

Aptorum Group Provides Update on DiamiR Biosciences Merger

Aptorum Group Limited (NASDAQ: APM) announced an anticipated merger with DiamiR Biosciences Corp. to form Niki BioSolutions, Inc., which will trade on NASDAQ under the ticker symbol 'NIKI' post-merger expected to close in July 2026. The company will undergo a 1-for-10 reverse stock split and redomesticate to Delaware to maintain NASDAQ listing comp…

Buy Tyler on the Dip: Public-Sector SaaS That AI Can't Replace (Yet)

Buy Tyler on the Dip: Public-Sector SaaS That AI Can't Replace (Yet)

Tyler Technologies is down big from its 2025 highs, but the business — mission-critical software for local governments — is structurally defensive and cash generative. This trade targets a rebound tied to cloud conversion progress, continued recurring revenue growth, and margin expansion as on-prem customers migrate. Entry, stop and target are laid…

Standard Nuclear Allocates Majority of IPO to Ten Largest Investors

Standard Nuclear Allocates Majority of IPO to Ten Largest Investors

Standard Nuclear Inc. assigned roughly 65% of the shares in its initial public offering to its 10 largest investors, with demand reportedly multiple times the reduced quantity of shares available. The company sold 10 million Class A shares at $15 apiece, raising $150 million, and the stock is scheduled to begin trading on the New York Stock Exchang…

Nike at a Crossroads: Turnaround Potential vs. Lingering Risks

Nike at a Crossroads: Turnaround Potential vs. Lingering Risks

Nike shares sit roughly 45% below their 52-week high, leaving investors split between seeing a deep-value turnaround and a stock that still faces material operational headwinds. A one-time $986 million IEEPA tariff recovery lifted reported Q4 FY2026 EPS to $0.72, while underlying EPS was $0.20. Key questions hinge on China demand, the pace of margi…

Piper Sandler Starts SpaceX Coverage at Neutral, Flags Near-Term Constraints

Piper Sandler Starts SpaceX Coverage at Neutral, Flags Near-Term Constraints

Piper Sandler opened coverage of SpaceX with a Neutral rating and a $156 price target, signaling confidence in the company’s multi-year potential but pointing to immediate headwinds that could restrict upside. The firm highlighted staged lockup expirations, uncertainty about a potential acquisition by Tesla, and large capital expenditure requiremen…

Goldman Posts Eye-Popping Q2 EPS Beat, Tops Big-Bank Peers on Triple Strength

Goldman Posts Eye-Popping Q2 EPS Beat, Tops Big-Bank Peers on Triple Strength

Goldman Sachs delivered a striking Q2 2026 performance, reporting EPS of $20.98 versus a $14.38 consensus and revenue of $20.34 billion against a $16.12 billion estimate. All six of the largest U.S. banks beat both EPS and revenue, but Goldman’s outperformance was the most pronounced, driven by a surge in investment banking fees, elevated trading r…

Market movers: Micron, AMD slide as select names rally across caps

Market movers: Micron, AMD slide as select names rally across caps

Equity markets displayed disparate performance across market-cap segments, with several large-cap technology and industrial names retreating and a handful of mid- and small-cap equities posting significant gains. Micron and AMD were among the larger decliners after company-specific developments were reported, while shares of several smaller compani…